H2-receptor antagonists, melatonin, and thiamine are some of the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.
Fuller Currie, PharmD Candidate 2021
Advertisement
Articles by Fuller Currie, PharmD Candidate 2021
Vitamin C and zinc are among the adjuvant treatments being evaluated for patients with COVID-19 due to their various immune-enhancing properties and possible antiviral effects.
Advertisement
Latest Updated Articles
Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Vitamin C and ZincPublished: June 22nd 2020 | Updated:
Evaluating the Efficacy of Adjunctive Therapies Used to Treat COVID-19: The Role of Famotidine, Melatonin, and ThiaminePublished: June 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
2
Experimental Vaccine Shows 73% Efficacy Against Salmonella Paratyphi A
3
Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate
4
Tezepelumab Improves Asthma Control, Reduces Reliance on Oral Corticosteriods
5
